COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva

Mostrar otras versiones (1)

Non-invasive SARS-CoV-2 antibody testing is urgently needed to estimate the incidence and prevalence of SARS-CoV-2 infection at the general population level. Precise knowledge of population immunity could allow government bodies to make informed decisions about how and when to relax stay-at-home dir...

Descripción completa

Detalles Bibliográficos
Autores principales: Randad, Pranay R., Pisanic, Nora, Kruczynski, Kate, Manabe, Yukari C., Thomas, David, Pekosz, Andrew, Klein, Sabra L., Betenbaugh, Michael J., Clarke, William A., Laeyendecker, Oliver, Caturegli, Patrizio P., Larman, H. Benjamin, Detrick, Barbara, Fairley, Jessica K., Sherman, Amy C., Rouphael, Nadine, Edupuganti, Srilatha, Granger, Douglas A., Granger, Steve W., Collins, Matthew, Heaney, Christopher D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273305/
https://www.ncbi.nlm.nih.gov/pubmed/32511537
http://dx.doi.org/10.1101/2020.05.24.20112300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273305/
https://www.ncbi.nlm.nih.gov/pubmed/32511537
http://dx.doi.org/10.1101/2020.05.24.20112300

Ejemplares similares